期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

生长抑制及DNA损伤诱导基因45在肝细胞性肝癌中的意义 被引量：1

原文传递
导出
摘要 生长抑制及DNA损伤诱导基因45（GADD45）家族是DNA损伤修复重要相关基因，最初从受紫外线（uV）照射的细胞分离得到，是电离辐射效应基因之二。GADD5家族属于p53、乳腺癌易感基因1（BRCA1）的下游基因，它广泛、稳定地表达在人体细胞特别是在静止期细胞中。
作者 瓦伦 佟辉 杨卫平 邱伟华
机构地区 上海交通大学医学院附属瑞金医院普外科上海消化外科研究所
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第1期187-188,共2页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目（81172326、30872511） 上海市自然科学基金资助项目（10ZR1419400）
关键词 DNA损伤修复 诱导基因 生长抑制 肝细胞性肝癌 乳腺癌易感基因 静止期细胞 相关基因 细胞分离
分类号 R735 [医药卫生—肿瘤]
  • 相关文献

参考文献15

  • 1Abdollabi A,Lord KA,Hoffman-Liebermann B. Sequence and expression of a cDNA encoding MyD11S:a novel myeloid differentiation primary response gene induced.by multiple cytokines[J].Oncogene,1991.165-167.
  • 2Lau WY. Primary liver tumors[J].Semin Surg Onco1,2000.135-144.
  • 3Chi H,Lu B,Takekawa M. GADD45beta/G ADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells[J].EMBO Journal,2004.1576-1786.
  • 4Rosemary Siafakas A,Richardson DR. Growth arrest and DNA damage-45 alpha (Gadd45a)[J].International Journal of Biochemistry & Cell Biology,2008.18.
  • 5Schrag JD,Jiralerspong S,Banville M. The crystal Structure and dimerization interface of Gadd45gamma[J].Proceedings of the National Academy of Sciences(USA),2008.6566-6571.
  • 6Wang T,Hu YC,Dong S. Co-activation of ERK,NF-kappaB,and GADD4Sbeta in response to ionizing radiation[J].Journal of Biological Chemistry,2005.12593-12601.
  • 7王佳玉,杨卫平,林大伟,衣琳,施敏敏,邱伟华.羟基脲对不同p53状态肝癌细胞中GADD45β的诱导差异及调控机制[J].中华实验外科杂志,2011,28(10):1632-1635. 被引量：2
  • 8Qiu w,David D,Zhou B. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma[J].American Journal of Pathology,2003.1961-1974.
  • 9Hermes M,Osswald H,Riehle R. Sadenosylhomocysteine hydrolase overexpression in HEK-293 cells:effect on intracellular adenosine levels,Cell Viability,and DNA Methylation[J].Cellular Physiology and Biochemistry,2008.223-236.
  • 10Dey A,Caro A,Cederbaum A. S-adenosyl methionine protects ob/ob mice from CYP2El-mediated liver injury[J].American Journal of Physiology-Gastrointestinal and Liver Physiology,2007.G91-G103.

二级参考文献38

  • 1Qiu W,David D,Zhou B,et al.Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.Am J Pathol,2003,162:1961-1974.
  • 2Qiu W,Zhou B,Zou H,et al.Hypermethylation of growth arrest DNA damage-inducible gene 45 β promoter in human hepatccellular carcinoma.Am J Pathol,2004,165:1689-1699.
  • 3Liu W,Li X,Chu ES,et al. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway. Hepatology,2011,53 : 843-853.
  • 4Qiu w, David D, Zhou B, et al. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol,2003,162 : 1961 -1974.
  • 5Qiu w, Zhou B, Chu PG, et al. The induction of growth arrest DNA damage-inducible gene 45β in Human hepatoma cell lines by S-aclenosyhnethionine. Am J Pathol,2007,171:287-296.
  • 6Lee YH, Andersen JB, Song HT, et al. Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma. Cancer Res,2010,70 : 8264-8269.
  • 7Qiu w, Zhou B, Zou H, et al. Hypermethylation of growth arrest DNA damage-inducible gene 45βpromoter in Human hepatocellular carcinoma. Am J Patho1,2004,165 : 1689-1699.
  • 8Shao J, Zhou B, Chu B, et al. Ribonucleotide reductase inhibitors and future drug design. Curr Cancer Drug Targets,2006,6:409-431.
  • 9Qiu W,Zhou B,Darwish D,et al. Characterization of enzymatic properties of Human ribonucleotide reductase holoenzyme reconstituted in vitro from hRRM1 ,hRRM2,and p53R2 subunits oxaliplatin. Biochem Biophys Res Commun,2006 ,340 :428-434.
  • 10Ou DL, Shen YC, Yu SL, et al. Induction of DNA damage-inducible gene GADIM5beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma ceils, Cancer Res,2010,70:9309-9318.

共引文献13

同被引文献13

  • 1Ince V, Aydin C, Otan E, et al. Comparison of plasmapheresis and molecular adsorbent recirculating system efficacy in graft failure after living donor liver transplantation[J]. Transplant Proc, 2013 , 45 ( 3 ) : 971-973.
  • 2Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson' s disease[J].J Clin Apher, 2012,27 (5) :282-286.
  • 3Podoll AS, DeGolovine A, Finkel KW. Liver support systems-a review[Il.ASAIOJ,2012,58(5) :443-449.
  • 4Stephens LA, Barclay AN, Mason D. Phenotypic characterization of regulatory CD4 + CD25 + T cells in rats[J] . Int Immunol, 2004 , 16 (2) :365-375.
  • 5Salama P, Phillips M, Grieu F, et al. Tumor-infiltrating Foxp3 + T regulatory cells show strong prognostic significance in colorectal cancer[J].J Clin Oncol,2009,27 (2) :186-192.
  • 6Trzonkowski P, Szmit E, MysliwaskaJ , et al. CD4 + CD25 + T regulatory cells inhibit cytotoxic activity of T CDS + and NK lymphocytes in the direct cell-to-cell interaction[J]. Clin Immunol, 2004, 112 ( 3 ) : 258-267.
  • 7Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17 -produ- cing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2Iineages[J]. Immunol,2005 ,6(11): 1123-1132.
  • 8Ivanov S, Linden A. Interleukin-17 as a drug target in human disease[J] . Trends Pharmacol Sci, 2009 ,30 (2) : 95 -103.
  • 9Nakae S, Saijo S, Horai R, et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist[J]. Proc Natl Acad Sci U S A,2003,100(10) :5986-5990.
  • 10Hsieh HG, Loong CC, Lui WY, et al. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection[J]. Transpl Int,2001 ,14(5) :287-298.

引证文献1

二级引证文献3

中华实验外科杂志
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部